日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Encapsulation of Fish Oil in Pullulan/Sodium Caseinate Nanofibers: Fabrication, Characterization, and Oxidative Stability

鱼油在普鲁兰/酪蛋白酸钠纳米纤维中的包封：制备、表征和氧化稳定性

期刊:Foods
影响因子:5.1
doi:10.3390/foods14213677
Dabora, Suaad; Jiang, Bo; Hlaing, Khin Su Su
Fish
发表日期：2025
文献求助 收藏

Endoscopic management of a post-gunshot biliary injury in a conflict zone: a case report from Sudan

苏丹枪伤后胆道损伤的内镜治疗：一例病例报告

期刊:Journal of Surgical Case Reports
影响因子:0.5
doi:10.1093/jscr/rjaf730
Dabora, Abderrahaim Ali; Abdalla, Hala Ibrahim; Rafei, Ahmed; Bedab, Abdalla; Ganim, Mohammed; Mohamed, Fayad Mohamed Alzain; Omer, Maha; Abdo, Abdelmoneim Eltayeb
发表日期：2025
文献求助 收藏

In vitro potency and pharmacokinetics of APG777, a novel anti-IL-13 mAb.

新型抗IL-13单克隆抗体APG777的体外效力和药代动力学。

期刊:Journal of Allergy and Clinical Immunology Global
影响因子:
doi:10.1016/j.jacig.2025.100545
Zhu Eric, Prentice Holly, Oh Jason, Shaheen Hussam, Gandhi Namita A, Wickman Grant, Dabora Rebecca, Dambkowski Carl L, Dillinger Lukas
单克隆抗体
IL-13
发表日期：2025
文献求助 收藏

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone

在TOURMALINE-MM1研究中，调整后续治疗后发现，在来那度胺和地塞米松的基础上加用伊沙佐米可显著改善总生存期。

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2023.283713
Ramasamy, Karthik; Bahlis, Nizar J; Kumar, Shaji K; Kumar, Arun; Cranmer, Holly; Wang, Bingxia; Dabora, Jonathan; Labotka, Richard; Richardson, Paul G; Moreau, Philippe
多发性骨髓瘤
发表日期：2024
文献求助 收藏

Jejunal angiodysplasia: surgery can be life-saving - a case report

空肠血管发育不良：手术可挽救生命——病例报告

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000001799
Dabora, Abderrahaim A; Nogoud, Alaedeen; Abdulsakhi, Muntasir; Rafei, Ahmed; Khalifa, Hossam A
发育与干细胞
发表日期：2024
文献求助 收藏

Estimating the impact of the COVID-19 vaccination programme in Ireland: December 2021-March 2023

评估爱尔兰新冠疫苗接种计划的影响：2021年12月至2023年3月

期刊:Pan African Medical Journal
影响因子:1
doi:10.11604/pamj.supp.2020.37.37.26742
Ilesanmi, Olayinka Stephen; Bello, Ayomide Esther; Afolabi, Aanuoluwapo Adeyimika; Cranmer, Holly; Podkonjak, Tanja; Benson, Eugene; Dabora, Jonathon; Jackson, Graham H; Marron, L; Mateo-Urdiales, A; O’Donnell, J; Robinson, E; Domegan, L
微生物学
新冠
发表日期：2024
文献求助 收藏

Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United States

美国接受伊沙佐米或达雷妥尤单抗联合来那度胺和地塞米松治疗的复发/难治性多发性骨髓瘤患者的医疗保健费用

期刊:
影响因子:
doi:10.18553/jmcp.2024.24085
Ailawadhi, Sikander; Cheng, Mu; DerSarkissian, Maral; Dabora, Jonathan; Young, Melanie; Noga, Stephen J; Pi, Selina; Zhang, Melody; Banatwala, Azeem; Duh, Mei Sheng; Cherepanov, Dasha
多发性骨髓瘤
骨髓瘤
发表日期：2024
文献求助 收藏

Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit

外科病房患者的血栓预防：临床审核

期刊:Vascular Health and Risk Management
影响因子:2.8
doi:10.2147/VHRM.S418808
Abdalla, Yassin Abdelrahim; Kamil, Arwa Mustafa; Mohamed, Samya Abbas Abdelrazig; Mohamed, Ahmed Hashim Ahmed; Khalifa, Eman; Mohamed, Mohamed Hamid Abdelsalam; Abdelgadir, Eilaf Eltayeb Abdalla; Dabora, Muawiya; Awoda, Mohammed Salah Eldin Mohammed Elshikh
心血管
发表日期：2023
文献求助 收藏

Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States

美国复发/难治性多发性骨髓瘤患者常用蛋白酶体抑制剂-免疫调节药物三联疗法的医疗保健成本和资源利用情况比较

期刊:
影响因子:
doi:10.18553/jmcp.2023.23031
Sanchez, Larysa; Chari, Ajai; Cheng, Mu; Cherepanov, Dasha; DerSarkissian, Maral; Huang, Fei; Stull, Dawn Marie; Dabora, Jonathan; Young, Melanie; Noga, Stephen J; Pi, Selina; Zhang, Melody; Banatwala, Azeem; Duh, Mei Sheng; Ailawadhi, Sikander
多发性骨髓瘤
免疫/内分泌
骨髓瘤
发表日期：2023
文献求助 收藏

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

一项随机、安慰剂对照临床试验，旨在评估巴姆拉尼维单抗和依特塞维单抗联合治疗高危门诊COVID-19患者的疗效，并验证持续高病毒载量的预后价值。

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciab912
Dougan, Michael; Azizad, Masoud; Mocherla, Bharat; Gottlieb, Robert L; Chen, Peter; Hebert, Corey; Perry, Russell; Boscia, Joseph; Heller, Barry; Morris, Jason; Crystal, Chad; Igbinadolor, Awawu; Huhn, Gregory; Cardona, Jose; Shawa, Imad; Kumar, Princy; Blomkalns, Andra; Adams, Andrew C; Van Naarden, Jacob; Custer, Kenneth L; Knorr, Jack; Oakley, Gerard; Schade, Andrew E; Holzer, Timothy R; Ebert, Philip J; Higgs, Richard E; Sabo, Janelle; Patel, Dipak R; Dabora, Matan C; Williams, Mark; Klekotka, Paul; Shen, Lei; Skovronsky, Daniel M; Nirula, Ajay
微生物学
发表日期：2022
文献求助 收藏